News Releases

Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.

Organization also premieres a suite of new products designed to improve operational efficiency and drive clinical excellence. NYON, Switzerland—(June 12, 2017) — Today at the 22nd IFCC-EFLM...

Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis BREA, Calif. — (April 20, 2017) — Beckman Coulter Diagnostics announced a...

Beckman Coulter Diagnostics announces FDA clearance and U.S. commercial launch of its new DxC 700 AU chemistry analyzer. The new system brings together the advanced capabilities of two successful...

DETROIT, Mich — (Dec. 16, 2016) — Henry Ford Health System Pathology and Laboratory Medicine today announced a partnership with Beckman Coulter Inc. that enhances and streamlines operations by...

BREA, Calif. — (Oct. 21, 2016) — Atlanta's Grady Health System is the first in the Southeastern United States to improve its patient care through Beckman Coulter's multi-disciplinary Power...

BREA, Calif. — (Oct. 17, 2016) — Beckman Coulter Diagnostics is pleased to announce FDA clearance and the commercial release of its new Access TSH (3rd IS) assay for use with the Access Family...

BREA, Calif. — (Oct. 13, 2016) — PCL Alverno (Hammond, Ind.), recipient of the prestigious ADVANCE Laboratory of the Year award for 2016, will share its strategies for implementing a culture...

SALUGGIA (VC) and BREA, Calif. (USA) — (August 30, 2016) — DiaSorin (FTSE Italia Mid Cap: DIA), a global leader in in vitro diagnostics immunoassay specialty testing, and Beckman Coulter...

Beckman Coulter Addresses Critical Factors for Clinical Laboratories to Move Healthcare Forward BREA, Calif. — (August 2, 2016) — Today at the 68th AACC Annual Scientific Meeting and Clinical...

The Sentinel Pancreatic Amylase is Available for Use on the Beckman Coulter AU Clinical Chemistry Analyzers BREA, Calif. — (June 23, 2016) — Beckman Coulter Diagnostics is pleased to announce...

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs; Expands Reach for Ortho and Broadens Menu for Beckman Coulter BREA, Calif., and RARITAN, N.J. —...

PROSTATE HEALTH INDEX (phi) BLOOD TEST GIVES YOU MORE CONFIDENCE BEFORE BIOPSY, REDUCING UNNECESSARY BIOPSIES BY 30% BREA, Calif. — (May 6, 2016) — Beckman Coulter Diagnostics, a leader in...

Access Anti-Müllerian Hormone (AMH) Assay Voted Best New Clinical Product of 2014 BREA, Calif. — (August 31, 2015) — Beckman Coulter Diagnostics’ automated Access Anti-Müllerian Hormone...

Standardized Processes and Improved Operational Efficiency Move Healthcare Forward BREA, Calif. — (July 24, 2015) — Beckman Coulter Diagnostics will be showcasing its comprehensive portfolio...

Saluggia (VC) and Brea, Calif. (USA) — (July 20, 2015) — DiaSorin (FTSE Italia Mid Cap: DIA) and Beckman Coulter Diagnostics, a global leader in clinical diagnostics, are pleased to announce...

Booths #D23 and D24, Level 2, Showcase Innovative Workflow Solutions Which Move Labs Forward NYON, Switzerland – (June 15, 2015) — Beckman Coulter Diagnostics supports IFCC-EFLM EuroMedLab...

HERCULES, Calif. and BREA, Calif. – April 20, 2015 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products and Beckman...

WHAT: In an upcoming ribbon-cutting ceremony and laboratory tour PCL Averno, a full service, community-based medical laboratory, in partnership with Beckman Coulter Diagnostics, will unveil its...

Beckman Coulter Diagnostics, a world leader in the IVD industry, and Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced a Molecular Diagnostic assay...

Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology...

Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non-invasive blood test that is three...